A Nigerian born Doctor Based in the U.S. now trends after announcing in a Video that she has been able to Cure up to 350 Covid-19 Patients. Find Out More!!

Dr Stella Immanuel

Dr Stella Immanuel, a Nigerian-born and train physician based in the United States has been trending on social media after COVID-19 speech on Monday.
Speaking at a news conference in Washington, Dr. Immanuel claimed that antimalarial drug, hydroxychloroquine, zinc, and antibacterial drug, Zithromax, were effective cures for the virus.
The Nigerian spoke during a news conference held by a group of American doctors under the aegis of “America’s Frontline Doctors” in front of the U.S. Supreme Court in Washington DC.
The doctors are holding a two-day “White Coat Summit” at the Capitol Hill to address what they call a “massive disinformation campaign” surrounding the virus.
Dr. Immanuel dismissed experts’ warning that hydroxychloroquine could cause serious heart problems for coronavirus patients, citing her experience with the use of the drug.
She said that she had successfully treated about 350 patients with hydroxychloroquine, zinc, and Zithromax.
Recall that we posted a report on the touting of hydroxychloroquine by President Donald Trump as cure for the virus. Dr. Immanuel has said it could also prevent the disease.


“I know you’re going to tell me that you treated 20 people, 40 people, and it didn’t work. I’m a true testimony.
“So I came here to Washington DC to tell America nobody needs to get sick. This virus has a cure. It is called hydroxychloroquine, zinc, and Zithromax.”
“I know you people want to talk about a mask. Hello? You don’t need mask. There is a cure.
“I know they don’t want to open schools. No, you don’t need people to be locked down. There is prevention and there is a cure,” she said.
Here is a video of her speech:


The good doctor has been decribed as a ‘warrior’ by Dr Simone Gold, a Los Angeles-based emergency medicine specialist, who moderated the news conference.

Leave a Reply

Your email address will not be published. Required fields are marked *